New York has passed regulations requiring buyers to be at least 21 to purchase kratom, tightening access to a substance doctors say is driving a fast-growing addiction problem.
More than 100 New York overdose deaths in a one-year period listed kratom as a cause, while the governor’s office said nearly 1% of U.S. young people reported using it in the past year.
SPARC clinicians said kratom and its concentrated form 7-OH act on opioid receptors, with 7-OH described as more potent than morphine and linked to faster dependency and harsher withdrawal.
Patients in recovery said the products were easy to buy over the counter, initially seemed to replace opioids, then became costly addictions—one man estimated spending nearly $50,000 in two years.
The move adds state limits to a product not federally regulated or FDA-approved, as New York weighs broader legislation and some states and localities already ban it.
Is the 'herbal remedy' in your local store actually fueling the next wave of the opioid crisis?
As states crack down on 'gas station heroin,' are we prepared for the public health fallout?
Kratom in Crisis: Surge in Poison Center Calls Drives New York and California to Crack Down on Synthetic Derivatives (2015–2025)
Overview
New York and California have recently taken strong actions to address the risks of kratom, especially its potent synthetic forms like 7-hydroxymitragynine. New York now requires clear labeling and warnings on kratom products to better inform consumers and protect public health, responding to concerns about youth use and past lack of information. Meanwhile, California has made kratom and its synthetic derivatives illegal for sale, leading to widespread product removals. These efforts reflect growing worries about addiction, contamination, and serious health risks, and signal a possible move toward more unified federal regulations as authorities respond to rising poison center calls and evolving challenges.